About Us Services Careers FAQ Contact Us 0
Home Medical Devices Deep Brain Stimulation Devices Market Size & Demand Analysis | 2033
Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market Size, Share & Trends Analysis Report By Applications (Parkinsons Disease, Epilepsy, Dystonia, Essential Tremor, Obsessive-compulsive disorder, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRMD54559DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Deep Brain Stimulation Devices Market Introduction
    2. By Applications
      1. Introduction
        1. Applications By Value
      2. Parkinsons Disease
        1. By Value
      3. Epilepsy
        1. By Value
      4. Dystonia
        1. By Value
      5. Essential Tremor
        1. By Value
      6. Obsessive-compulsive disorder
        1. By Value
      7. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Neurological Clinics
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Applications
      1. Introduction
        1. Applications By Value
      2. Parkinsons Disease
        1. By Value
      3. Epilepsy
        1. By Value
      4. Dystonia
        1. By Value
      5. Essential Tremor
        1. By Value
      6. Obsessive-compulsive disorder
        1. By Value
      7. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Neurological Clinics
        1. By Value
      5. Others
        1. By Value
    4. U.S.
      1. By Applications
        1. Introduction
          1. Applications By Value
        2. Parkinsons Disease
          1. By Value
        3. Epilepsy
          1. By Value
        4. Dystonia
          1. By Value
        5. Essential Tremor
          1. By Value
        6. Obsessive-compulsive disorder
          1. By Value
        7. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Neurological Clinics
          1. By Value
        5. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Applications
      1. Introduction
        1. Applications By Value
      2. Parkinsons Disease
        1. By Value
      3. Epilepsy
        1. By Value
      4. Dystonia
        1. By Value
      5. Essential Tremor
        1. By Value
      6. Obsessive-compulsive disorder
        1. By Value
      7. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Neurological Clinics
        1. By Value
      5. Others
        1. By Value
    4. U.K.
      1. By Applications
        1. Introduction
          1. Applications By Value
        2. Parkinsons Disease
          1. By Value
        3. Epilepsy
          1. By Value
        4. Dystonia
          1. By Value
        5. Essential Tremor
          1. By Value
        6. Obsessive-compulsive disorder
          1. By Value
        7. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Neurological Clinics
          1. By Value
        5. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Applications
      1. Introduction
        1. Applications By Value
      2. Parkinsons Disease
        1. By Value
      3. Epilepsy
        1. By Value
      4. Dystonia
        1. By Value
      5. Essential Tremor
        1. By Value
      6. Obsessive-compulsive disorder
        1. By Value
      7. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Neurological Clinics
        1. By Value
      5. Others
        1. By Value
    4. China
      1. By Applications
        1. Introduction
          1. Applications By Value
        2. Parkinsons Disease
          1. By Value
        3. Epilepsy
          1. By Value
        4. Dystonia
          1. By Value
        5. Essential Tremor
          1. By Value
        6. Obsessive-compulsive disorder
          1. By Value
        7. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Neurological Clinics
          1. By Value
        5. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Applications
      1. Introduction
        1. Applications By Value
      2. Parkinsons Disease
        1. By Value
      3. Epilepsy
        1. By Value
      4. Dystonia
        1. By Value
      5. Essential Tremor
        1. By Value
      6. Obsessive-compulsive disorder
        1. By Value
      7. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Neurological Clinics
        1. By Value
      5. Others
        1. By Value
    4. UAE
      1. By Applications
        1. Introduction
          1. Applications By Value
        2. Parkinsons Disease
          1. By Value
        3. Epilepsy
          1. By Value
        4. Dystonia
          1. By Value
        5. Essential Tremor
          1. By Value
        6. Obsessive-compulsive disorder
          1. By Value
        7. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Neurological Clinics
          1. By Value
        5. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Applications
      1. Introduction
        1. Applications By Value
      2. Parkinsons Disease
        1. By Value
      3. Epilepsy
        1. By Value
      4. Dystonia
        1. By Value
      5. Essential Tremor
        1. By Value
      6. Obsessive-compulsive disorder
        1. By Value
      7. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Neurological Clinics
        1. By Value
      5. Others
        1. By Value
    4. Brazil
      1. By Applications
        1. Introduction
          1. Applications By Value
        2. Parkinsons Disease
          1. By Value
        3. Epilepsy
          1. By Value
        4. Dystonia
          1. By Value
        5. Essential Tremor
          1. By Value
        6. Obsessive-compulsive disorder
          1. By Value
        7. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Neurological Clinics
          1. By Value
        5. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Deep Brain Stimulation Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Aleva Neurotherapeutics SA
    3. Boston Scientific Corporation
    4. Medtronic plc
    5. Neuropace Inc.
    6. Nevro Corporation
    7. Neuronetics Inc.
    8. Functional Neuromodulation Ltd
    9. Beijing Pins Medical Co., Ltd.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global neurostimulation devices market size was valued at USD 6 billion in 2021 and is valued at USD 14 billion by 2030. The market is expected to grow at a CAGR of 13% during the forecast period (2022–2030). Factors such as increasing geri
Buy Now
Global Report
Market Overview The global sinus dilation devices market size was valued at USD 2,573 million in 2022. It is estimated to reach USD 5,217 million by 2031, growing at a CAGR of 10.79% during the forecast period (2023–2031). Sinusitis is an inf
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.